Keywords: roberts, develop, intranasal, emesis, drug, pharmaceutical, licensed

Roberts To Develop Intranasal Emesis Drug

Article | 22 July 1998

Roberts Pharmaceutical has licensed exclusive US, Canadian and Mexicanmarketing rights to RiboGene's Emitasol, an intranasal formulation of metoclopramide, which is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Metoclopramide

Reglan

Nystatin

Go to drug listing